Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment
| Conditions: | Malignant Pleural Mesothelioma |
| Start Date: | December 1, 2002 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT01243632 |
| Study Type: | Interventional |
| Intervention: | Drug: Prolonged 6-hr infusion of gemcitabine |
| Study Design: | Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Institute of Oncology Ljubljana|Supported by grants J3-3021 and J3-6044 from the Ministry of Higher Education, Science and Technology of the Republic of Slovenia |
| Ages: | Adult|Senior |
| Enrollment: | 78 |
| Funded By: | Other |
| First Received: | November 10, 2010 |
| End Date: | June 1, 2010 |
| Last Updated: | November 17, 2010 |
| Last Verified: | November 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
